Orlando, Florida – UCF College of Medicine researchers are developing a more effective way to treat glioblastoma — an aggressive, incurable form of brain cancer. Patients currently live just 12 to 15 months after diagnosis despite surgery, radiation and chemotherapy. New research led by Kiminobu Sugaya, a stem cell researcher...
Latest News
Chicago, Illinois – Liver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for treating advanced metabolic dysfunction-associated steatotic liver disease (MASLD) — formerly known as nonalcoholic fatty liver disease (NAFLD). Resmetirom (to be sold under the brand name Rezdiffra), received FDA approval on March 14, 2024....
Chicago, Ill. – Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically attacking cells that would otherwise form the key component of the body’s immunodefense system, white blood cells. In a new study published in Blood Advances, researchers from the UChicago...
Cincinnati, Ohio – The University of Cincinnati Cancer Center is the first site in the Midwest enrolling patients in a new Phase 2 clinical trial testing a vaccine to treat pancreatic cancer. According to the National Cancer Institute, more than 66,000 Americans will be diagnosed with pancreatic cancer in 2024....
San Diego, Ca – University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Hematology (ASH) Annual Meeting, held Dec. 9-12 in San Diego, California. Trial finds new drug shows promise to treat Chronic Lymphocytic Leukemia (CLL) Phase 2 clinical trial results suggest a new drug...
Cincinnati, OH – While the overall cancer death rate has been steadily declining in the U.S. since the 1990s, death rates due to pancreatic cancer are increasing. This is especially true in pancreatic cancer that has metastasized, or spread to a different part of the body. The National Cancer Institute...
Cincinnati, Ohio – While better screening and improved treatments are leading to better outcomes for patients with breast cancer, 90% of breast cancer deaths are a result of metastasis, or the cancer growing and spreading to other parts of the body. University of Cincinnati Cancer Center researchers in the lab...
Coimbra, Portugal – The body’s inability to produce enough insulin or use it effectively often results in type 2 diabetes (T2D), a chronic disease affecting hundreds of millions of people around the globe. Disease management is crucial to avoid negative long-term outcomes, such as limb amputation or heart disease. To...
Cologne, Germany – A team of researchers from the University of Cologne’s Faculty of Medicine and University Hospital Cologne, led by Dr Yuri Tolkach and Professor Dr Reinhard Büttner, has created a digital pathology platform based on artificial intelligence. The platform uses new algorithms developed by the team and enables...
Cologne, Germany – In the treatment of aggressive lymphomas and blood cancer (leukaemia), so-called chimeric antigen receptor T cells (CAR T cells) are increasingly being used. For this therapy, immune cells are taken from patients and programmed by means of genetic engineering to detect proteins on the malignant tumour cells....